The Safety of Pimavanserin for Parkinson's Disease and Efforts to Reduce Antipsychotics for People With Dementia

Am J Psychiatry. 2022 Aug;179(8):519-521. doi: 10.1176/appi.ajp.20220519.
No abstract available

Keywords: Alzheimer’s Disease; Antipsychotics; Clinical Drug Studies; Dementia; Parkinson’s Disease; Psychosis.

Publication types

  • Editorial

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Dementia* / drug therapy
  • Humans
  • Parkinson Disease* / drug therapy
  • Piperidines / adverse effects
  • Psychotic Disorders* / drug therapy
  • Urea / analogs & derivatives

Substances

  • Antipsychotic Agents
  • Piperidines
  • Urea
  • pimavanserin